Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.

Slides:



Advertisements
Similar presentations
Ask your patients about tobacco use. Act to help them quit.
Advertisements

Nicotine Gum Nicotine absorbed mucosal membranes 2mg and 4mg strength
A Clinical Flow-Chart for the “Treatment-Resistant Smoker”
Nicotine Addiction Pharmacy Practice II Winter 2005.
STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.
I do not have any relevant financial relationships to disclose.
Intervention and Promotion Makes a Difference Tobacco cessation intervention by healthcare providers improves quit rates. Brief counseling is all that.
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
Treatment of Tobacco Dependence in 2012 J. Taylor Hays, MD Professor of Medicine Associate Director Nicotine Dependence Center Mayo Clinic Rochester, MN.
Nurses’ Role with Clients/Patients Who Use Tobacco Created by the Registered Nurses’ Association of Ontario.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Systems Strategies to Address Tobacco Use: Utilizing EHRs to Improve Patient Care Ryan Reikowsky, MA, MPH Manager, Community Development Arizona Smokers’
Presinted by :Shahd Amer.  Tobacco ads may make you feel like everyone is doing it but they are not.  Only about 28% of high school students smoke.
Smoking Cessation: A Practical Overview of Pharmacotherapy Joseph Saseen, Pharm.D., FCCP, BCPS Professor University of Colorado
Nicotine Replacement Therapy: Administration and Overview Barbara Hart, MPA and Claudia Lechuga, MS Bronx BREATHES T: (718) E:
Treating Nicotine Dependence in Patients with Addictive Disorders Eric Heiligenstein, M.D. Director of Psychiatry University Health Services University.
Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.
Pharmacotherapy for the Treatment of Nicotine Dependence Donna Shelley, MD, MPH, Columbia University Mailman School of Public Health
Introduction to Smoking Cessation MSSM III Edward Anselm, M.D. Assistant Professor of Medicine Icahn School of Medicine at Mount Sinai Medical Director,
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
Hospitalization: Nursing Role with In-Patients Who Smoke Created by the Registered Nurses’ Association of Ontario.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Treating Tobacco Use.
Module 2 - Assessment, Diagnosis, and Pharmacotherapy: Integrating Tobacco Use Interventions into Chemical Dependence Services.
Tobacco Cessation: Curb the Deadliest Epidemic Keith Bradley, MD Director, Research Associates Program at St. Vincent’s National Alliance of Research Associates.
The Ohio Partners for Smoke-Free Families 5A’s
Quitting Smoking How to stop smoking … for good!.
Improving Children's Health by Addressing Family Tobacco Use Your name, institution, etc. here YOUR LOGO HERE (paste to each slide)
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
2010 PHS Clinical Practice Guidelines: Smoking Cessation CDR Sherri Yoder PharmD, BCPS, CER Program Principal Consultant Indian Health Service USPHS COA.
A presentation for [INSERT EVENT/ORGANIZATION] [INSERT DATE] [INSERT PRESENTER NAMES/ORGS]
Nicotine-related disorders Answers obtained from DSM-IV-TR and the AJP Supplement of August, 2006, on substance abuse As of 1Sep08.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Clinical Trials and Patient Education for Smoking Cessation Maureen George PhD RN AE- C FAAN University of Pennsylvania School of Nursing.
1 Treating Tobacco Use and Dependence 2008 UPDATE U.S. Public Health Service Clinical Practice Guideline.
An Updated Algorithm for Choosing Among Smoking Cessation Treatments John R. Hughes University of Vermont, USA
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
Addressing Tobacco Use within College Health Services National Conference of Tobacco or Health December 12, 2003 – Boston, MA Michael P. McNeil, M.S. Coordinator,
The Alabama Tobacco Quitline and July 22, 2010.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
Tobacco Cessation Strategies and Resources: Epidemiology, Evidence and Availability May 29, 2013 The National Tobacco-Free College Campus Initiative: Building.
July 2006 Treating Tobacco Use and Dependence. Learning Objectives At the end of this session you should understand: The impact of tobacco dependence.
Staff Training. MOQC/MCC Tobacco Cessation Patient Education Video: Why Cancer Patients Should Quit Tobacco.
Using Standardized Patients to Teach Smoking Cessation Susan Stangl, MD, MSEd David Geffen School of Medicine at UCLA.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
1 Smoking quiz Robert West University College London Rio de Janeiro 2006.
Types of help Available NHS Stop Smoking Services Nicotine Replacement Therapy (NRT) Other Pharmacological Treatments (non nicotine) Alternative Therapies.
1 Treating Nicotine Dependency Paul Zemann Public Health - Seattle & King County Tobacco Prevention Program th Ave, Suite 900 Seattle, WA 98104
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
Brief Intervention. Brief Intervention has a number of different definitions but usually encompasses: –assessment –provision of education, support and.
Smoking. Why people smoke and find it difficult to stop Smoking is an addictive habit. It is associated with strong cravings, dependency, tolerance, and.
Conclusions and Awards
Quick overview of quit smoking counseling for people with mental health or substance use disorders Associate Professor of.
Smoking Cessation Medication
Anita R. Webb, PhD JPS Family Medicine Residency
Assistant professor Family Medicine - Suez Canal University
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
Why and How to Quit Smoking
Changes to the UK licence for NRT: rationale
Get smoker to their baseline for their behavioral health condition and initiating abstinence from substances. Then assess whether, in the past year, was.
Tobacco Dependence Screening and Treatment in Behavioral Health Settings Prescribing.
Tobacco Cessation Guidelines for COPD
Treating Tobacco Dependence
ABCs of Behavioral Support
The “Nuts and Bolts” of Tobacco Cessation in the Clinical Setting
Tobacco Cessation for Primary Care Providers
Presentation transcript:

Smoking Cessation

Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit do so on their own, without evidence- based programs; more than 95 percent relapse. Using evidence-based programs can more than double success rates.

Brief interventions Minimal interventions lasting less than 3 minutes increase overall tobacco abstinence rates. Every tobacco user should be offered at least a minimal intervention, whether or not he or she is referred to an intensive intervention. Even when patients are not willing to make a quit attempt, clinician-delivered brief interventions enhance motivation and increase the likelihood of future quit attempts. STRENGTH OF EVIDENCE: A

Ask and Act Ask every patient about tobacco use. Act to help them quit.

Patients unwilling to quit Use brief intervention to promote motivation (motivational interviewing) Patients unwilling to quit may: – Lack information about harmful effects or benefits of quitting – Lack financial resources – Have fears or concerns about quitting – Think they can’t quit PHS Clinical Practice Guideline: Treating Tobacco Use and Dependence: 2008 Update

Counseling

Training Staff in Smoking Cessation Counseling What will constitute smoking cessation counseling in your setting? Ask (identify smoking/tobacco use status) Advise (advise patient to quit) Assess (determine interest/readiness to quit) Assist (in developing quit plan if ready to quit) Arrange (follow-up contact) Motivate (if patient not ready to quit) Prevent Relapse (if quit within past year)

Principles for Motivational Interviewing Express empathy Develop discrepancy Roll with resistance Support self-efficacy Motivational interviewing is effective in increasing future quit attempts.

Express empathy Open ended questions Reflective listening Normalize feelings and concerns Support right to choose whether or not to quit PHS Clinical Practice Guideline: Treating Tobacco Use and Dependence: 2008 Update

Withdrawal symptoms appear as soon as within 4 hours of taking last one. More symptoms remain in between three and five days and start to disappear within 2 weeks, though some may experience few symptoms even for months. Nicotine Withdrawal Symptoms

Pharmacotherapy

Who should receive it? All smokers trying to quit, except where contraindicated or for specific populations for which there is insufficient evidence of effectiveness (i.e., pregnant women, smokeless tobacco users, light smokers, and adolescents) STRENGTH OF EVIDENCE = A

First-line Pharmacotherapy Buproprion slow release Nicotine gum Nicotine inhaler Nicotine nasal spray Nicotine patch Nicotine lozenge Varenicline

Factors To Consider When Prescribing Clinician’s familiarity with medications Contraindications Patient preference Previous patient experience Patient characteristics (history of depression, weight gain concerns, etc.)

Nicotine Lozenge SR ($ $4.95) per day Available in 2mg or 4mg Weeks 1-6: one every 1-2 hours Weeks 7-9: one every 2-4 hours Weeks 10-12: one every 4-8 hours Common side effects are mouth soreness, dyspepsia and nausea.

Nicotine gum SR ($ $4.68) per day Available in 2mg or 4mg Weeks 1-6: one every 1-2 hours Weeks 7-9: one every 2-4 hours Weeks 10-12: one every 4-8 hours Common side effects are jaw pain and mouth soreness.

Nicotine patch SR ($ $3.89) per day >25 cigarettes per day: 21mg every 24hrs for four weeks, then 14mg for two weeks, then 7 mg for two weeks Common side effects are skin irritation or sleep issues if worn at night.

Nicotine inhaler SR ($7.32) per day (6 cartridges) 6-16 cartridges per day, initially one every 1-2 hours Common side effects are mouth and throat irritation and cough.

Nicotine Nasal Spray 14.7 SR ($3.92) per day 1-2 doses (2-4 sprays) per hour Common side effects are nose and throat irritation, sneezing and cough.

Bupropion Slow Release Start 150mg once daily for 6 days, then twice per day for seven to twelve weeks. Plan quit date 1-2 weeks after start of treatment. Approved for up to 6 months Common side effects include Insomnia and dry mouth.

Varenicline Start 0.5mg daily for 1-3 days, then increase to twice daily for 1-4 days. Increase to 1 mg twice daily on quit date. Take after eating and with a full glass of water. Consider dosage reduction in patients unable to tolerate the adverse reactions. Treat for 12 wk. For patients who have successfully stopped smoking after 12 wk, an additional 12-wk course may increase the likelihood of long-term abstinence. Most common side effects are nausea and vivid dreams. Monitor for psychiatric symptoms.

23 Medication Recommendation Certain combinations of first-line medications have been shown to be effective smoking cessation treatments. Therefore, consider using these combinations of medications for patients who are willing to quit. Effective combination medications are: * Long-term (> 14 weeks) nicotine patch + other NRT (gum and spray) * The nicotine patch + the nicotine inhaler * The nicotine patch + bupropion SR. (Strength of Evidence = A)